EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Surveillance for invasive candidiasis in China (CHIF-NET 2018-2021): rising antifungal resistance observed in a nationwide longitudinal study

Qiao-Lian Yi, Kai-Wen Xu, Peng-Hao Guo, Li Li, Ling Ma, Ya Liu, Ning Li, Xiao-Chun Huang, Hong He, Wen-Ying Xia, Jing Guan, Jin Li und 9 weitere

Antimicrobial Agents and Chemotherapy · 03.06.2026 · 70 (6)

DOI: 10.1128/aac.00035-26 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.06.2026. Verfasst von Qiao-Lian Yi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy o…. Hauptthemen laut MEDLINE: Antifungal Agents, Candida, Candidiasis, Invasive, Drug Resistance, Fungal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, The National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive candidiasis (IC) is a severe infection primarily affecting immunocompromised patients and is associated with high mortality and substantial hospital costs. Accurate regional data on epidemiology and antifungal resistance of IC are crucial for effective clinical management. The China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study is a laboratory-based multicenter study initiated in August 2009. This report presented updated data from August 2017 to December 2021, involving 76 hospitals across 28 provincial regions in China, and included a 12-year longitudinal analysis. Isolates from patients with IC were assigned to species level by matrix-assisted laser desorption ionization-time of flight mass spectrometry and internal transcribed spacer rDNA sequencing. Susceptibility testing was performed for nine antifungal agents using the broth microdilution method. A total of 11,679 Candida isolates were collected. Candida albicans was the most common Candida species (46.0%), followed by Candida tropicalis (17.6%), Candida parapsilosis sensu stricto (15.6%), and Candida glabrata sensu stricto (11.2%). Antifungal resistance rates showed notable variations among different Candida species, with the highest azole resistance observed in C. tropicalis isolates causing candidemia (42.5% to fluconazole and 38.9% to voriconazole). Cross- and multi-drug resistance to azoles and echinocandins was observed in all predominant Candida species. The species distribution of major Candida pathogens causing IC remained stable in China, while antifungal resistance increased, especially among non- albicans Candida species. Enhanced surveillance, accurate species identification, and strengthened antifungal stewardship are needed to address the growing challenge of antifungal resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidaCandidiasis, InvasiveDrug Resistance, FungalHumansCandida albicansCandida tropicalisChinaLongitudinal StudiesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antifungal resistancecandidiasisinvasive fungal diseasessurveillance

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Laboratory of Mycology, Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, China.
  • Department of Clinical Laboratory, Provincial Hospital Affiliated to Fuzhou University, Fuzhou, China.

ORCID-Profile: Jing-Jia Zhang, Ying-Chun Xu, Meng Xiao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • The National High Level Hospital Clinical Research Funding
  • Peking Union Medical College Hospital Talent Cultivation Program Category C
  • Peking Union Medical College Hospital Talent Cultivation Program Category D
  • Young Elite Scientists Sponsorship Program of the Beijing High Innovation Plan
  • the CAMS Innovation Fund for Medical Sciences (CIFMS)

Zitieren

APA

Yi, Q. L., Xu, K. W., Guo, P. H., Li, L., Ma, L., Liu, Y., Li, N., Huang, X. C., He, H., Xia, W. Y., Guan, J., Li, J., Zhang, G., Kang, W., Zhang, J. J., Wang, T., Gao, H. T., Guo, D., Xu, Y. C., …, & China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group (2026). Surveillance for invasive candidiasis in China (CHIF-NET 2018-2021): rising antifungal resistance observed in a nationwide longitudinal study. Antimicrobial Agents and Chemotherapy, 70(6). https://doi.org/10.1128/aac.00035-26

Vancouver

Yi QL, Xu KW, Guo PH, Li L, Ma L, Liu Y, et al. Surveillance for invasive candidiasis in China (CHIF-NET 2018-2021): rising antifungal resistance observed in a nationwide longitudinal study. Antimicrobial Agents and Chemotherapy. 2026;70(6). doi:10.1128/aac.00035-26

BibTeX
@article{Yi2026,
  author = {Yi, Qiao-Lian and Xu, Kai-Wen and Guo, Peng-Hao and Li, Li and Ma, Ling and Liu, Ya and Li, Ning and Huang, Xiao-Chun and He, Hong and Xia, Wen-Ying and Guan, Jing and Li, Jin and Zhang, Ge and Kang, Wei and Zhang, Jing-Jia and Wang, Tong and Gao, Hao-Tian and Guo, Dan and Xu, Ying-Chun and Xiao, Meng and China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group, China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group},
  title = {Surveillance for invasive candidiasis in China (CHIF-NET 2018-2021): rising antifungal resistance observed in a nationwide longitudinal study},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {6},
  doi = {10.1128/aac.00035-26}
}
Kostenlos starten →